|
Rheumatoid Arthritis
Citations 181-190 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- CLINICAL
The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry
- J. Carbonell, T. Cobo, A. Balsa, M. Á. Descalzo, L. Carmona, and SERAP Study Group
Rheumatology 2008; 47: 1088-1092.
[Abstract]
[Full Text]
- GUIDELINES
Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context
- E. R. Soriano, C. Galarza-Maldonado, M. H. Cardiel, B. A. Pons-Estel, L. Massardo, C. V. Caballero-Uribe, A. F. Achurra-Castillo, L. A. Barile-Fabris, J. Chávez-Corrales, J. F. Díaz-Coto, M. H. Esteva-Spinetti, M. Guibert-Toledano, F. Irazoque Palazuelos, M. W. Keiserman, A. V. Lomonte, L. M. H. Mota, C. Pineda Villaseñor, and G. S. Alarcón on behalf of GLADAR (Grupo Latino Americano de Estudio de Artritis Reumatoide)
Rheumatology 2008; 47: 1097-1099.
[Extract]
[Full Text]
[ full guidelines ]
- CASE REPORTS
Multicentric reticulohistiocytosis: a lesson in screening for malignancy
- A. Millar, D. O’Kane, and A. Taggart
Rheumatology 2008; 47: 1102-1103.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Modelling the cost effectiveness of TNF antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry
- R. F. van Vollenhoven
Rheumatology 2008; 47: 1106-1107.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry: reply
- N. Bansback, A. Brennan, D. Symmons, R. Nixon, J. Madan, M. Harrison, and K. Watson
Rheumatology 2008; 47: 1107-a.
[Extract]
[Full Text]
- ARTICLES
Oestrogens in rheumatic diseases: friend or foe?
- M. Cutolo, S. Capellino, and R. H. Straub
Rheumatology 2008; 47: iii2-iii5.
[Abstract]
[Full Text]
- REVIEWS
Interleukin-7 in rheumatoid arthritis
- S. M. Churchman and F. Ponchel
Rheumatology 2008; 47: 753-759.
[Abstract]
[Full Text]
- REVIEWS
Sweet and sour: the impact of sugars on disease
- A. Alavi and J. S. Axford
Rheumatology 2008; 47: 760-770.
[Abstract]
[Full Text]
- REVIEWS
Signalling, inflammation and arthritis: Crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity
- V. Paunovic, H. P. Carroll, K. Vandenbroeck, and M. Gadina
Rheumatology 2008; 47: 771-776.
[Abstract]
[Full Text]
- BASIC SCIENCE
Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF- monoclonal antibody, infliximab
- N. Sekiguchi, S. Kawauchi, T. Furuya, N. Inaba, K. Matsuda, S. Ando, M. Ogasawara, H. Aburatani, H. Kameda, K. Amano, T. Abe, S. Ito, and T. Takeuchi
Rheumatology 2008; 47: 780-788.
[Abstract]
[Full Text]
[ Supplementary Data ]
|
|
